The Daily29 Des 2024

The Sunday Read: ‘Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.’

For decades, Big Food has been marketing products to people who can’t seem to stop eating, and now, suddenly, they can. The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain.

Around seven million Americans take these drugs, but estimates from Morgan Stanley suggest that number could increase to 24 million within the next decade. More than 100 million American adults are obese, and the drugs may eventually be rolled out to people who don’t have diabetes or obesity, as they seem to tame addictions beyond food — appearing to make cocaine, alcohol and cigarettes more resistible. Research is at an early stage, but the drugs may also cut the risk of stroke, heart and kidney disease, Alzheimer’s and Parkinson’s.

Major food companies are scrambling to research the impact of the drugs on their brands — and figure out how to adjust. But for Mattson, which has invented products for the nation’s biggest food conglomerates for nearly 50 years, the Ozempic threat could be a boon.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2918)

From Trump’s Attorney to Attorney General: The Rise of Todd Blanche

To be confirmed as the next attorney general, Todd Blanche must convince members of the U.S. Senate that as political as the Department of Justice has become, it would be even worse without him on top...

15 Jul 29min

Why the Cease-Fire With Iran Keeps Crumbling

After back-and-forth attacks and an exchange of fiery language between President Trump and Iran’s leaders, it appears that both sides have returned to open conflict. Today, David Sanger, the White Hou...

14 Jul 27min

Why Are Grocery Store Prices So High

According to the Economic Research Service at the Department of Agriculture, prices across all food categories are expected to rise 3.2 percent in 2026. Today, Jessica Cheung, a senior audio producer ...

13 Jul 37min

What’s Epic About the ‘Odyssey’? Everything.

This Friday, “The Odyssey,” directed by Christopher Nolan, hits theaters. Even before the movie’s release, though, it’s proving to be a cultural event. Spirited discussions of Nolan’s cinematic interp...

12 Jul 50min

Mick Jagger Knows He May Have Played His Last Rolling Stones Show

The legendary rock star, now 82, on how fame, touring and aging have changed him. Thoughts? Email us at theinterview@nytimes.com Watch our show on YouTube: youtube.com/@TheInterviewPodcast For tra...

11 Jul 1h 2min

Cuba Under Siege

In January, after the capture of President Nicolás Maduro of Venezuela, the Trump administration turned its attention to Cuba. In the months since, the White House has used every tool at its disposal ...

10 Jul 47min

The Unprecedented Personal Profits of Trump’s Presidency

A recent financial disclosure shows that President Trump has made $2.2 billion since he returned to office. Today, Eric Lipton, a New York Times investigative reporter, reveals the Trump family’s next...

9 Jul 29min

The Implosion of Graham Platner

The campaign for Graham Platner, the Democratic nominee for Senate from Maine, imploded this week after he was accused of rape. Lisa Lerer and Shane Goldmacher, national political correspondents for T...

8 Jul 35min